Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1963 1
1964 2
1965 25
1966 21
1967 46
1968 67
1969 62
1970 57
1971 52
1972 48
1973 71
1974 53
1975 78
1976 69
1977 47
1978 44
1979 33
1980 39
1981 35
1982 37
1983 27
1984 38
1985 34
1986 33
1987 47
1988 35
1989 41
1990 41
1991 41
1992 79
1993 67
1994 59
1995 87
1996 83
1997 113
1998 162
1999 161
2000 176
2001 175
2002 193
2003 226
2004 266
2005 345
2006 400
2007 438
2008 439
2009 454
2010 530
2011 573
2012 639
2013 688
2014 612
2015 684
2016 625
2017 726
2018 711
2019 384
2020 17
Text availability
Article attribute
Article type
Publication date

Search Results

10,277 results
Results by year
Filters applied: . Clear all
Page 1
Anti-Obesity Therapy: from Rainbow Pills to Polyagonists.
Müller TD, Clemmensen C, Finan B, DiMarchi RD, Tschöp MH. Müller TD, et al. Pharmacol Rev. 2018 Oct;70(4):712-746. doi: 10.1124/pr.117.014803. Pharmacol Rev. 2018. PMID: 30087160 Review.
Combination therapy for obesity.
Wilding JP. Wilding JP. J Psychopharmacol. 2017 Nov;31(11):1503-1508. doi: 10.1177/0269881117737401. Epub 2017 Nov 13. J Psychopharmacol. 2017. PMID: 29132230 Review.
Progress and challenges in anti-obesity pharmacotherapy.
Bessesen DH, Van Gaal LF. Bessesen DH, et al. Lancet Diabetes Endocrinol. 2018 Mar;6(3):237-248. doi: 10.1016/S2213-8587(17)30236-X. Epub 2017 Sep 14. Lancet Diabetes Endocrinol. 2018. PMID: 28919062 Review.
FDA-Approved Anti-Obesity Drugs in the United States.
Daneschvar HL, Aronson MD, Smetana GW. Daneschvar HL, et al. Am J Med. 2016 Aug;129(8):879.e1-6. doi: 10.1016/j.amjmed.2016.02.009. Epub 2016 Mar 4. Am J Med. 2016. PMID: 26949003 Review.
10,277 results
Jump to page
Feedback